Evidence map›Paper›PMID 41928471›Full record

ArticleHGG advances2026

Broadening the phenotypic and molecular spectrum of PRS deficiency in females.

Tamara Braid, Sydney Scholten, Sangeetha Yoganathan, Abrar K Alsalamah, Daniel Deschênes, Ghislain Deslongchamps, Sharan Goobie, Elise Heon, Ingrid Tein, Ashish R Deshwar

Abstract readCase Reports
In one paragraph

Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tamara BraidDivision of Clinical and Metabolic Genetics, the Hospital for Sick Children, Toronto, ON, Canada; Department of Paediatric Laboratory Medicine, the Hospital for Sick Children, Toronto, ON, Canada.
Sydney ScholtenProgram in Developmental and Stem Cell Biology, SickKids Research Institute, Toronto, ON, Canada; Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada; Faculty of Medicine, Dalhousie University, Saint John, NB, Canada.
Sangeetha YoganathanDivision of Neurology, Department of Pediatrics, the Hospital for Sick Children, Toronto, ON, Canada.
Abrar K AlsalamahDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada; Department of Ophthalmology, the Hospital for Sick Children, Toronto, ON, Canada; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Daniel DeschênesFaculty of Medicine, Dalhousie University, Saint John, NB, Canada; Department of Chemistry, University of New Brunswick, Fredericton, NB, Canada.
Ghislain DeslongchampsDepartment of Chemistry, University of New Brunswick, Fredericton, NB, Canada.
Sharan GoobieMaritime Medical Genetics Service, IWK Health, Halifax, NS, Canada; Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.
Elise HeonDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada; Department of Ophthalmology, the Hospital for Sick Children, Toronto, ON, Canada.
Ingrid TeinDivision of Neurology, Department of Pediatrics, the Hospital for Sick Children, Toronto, ON, Canada.
Ashish R DeshwarDivision of Clinical and Metabolic Genetics, the Hospital for Sick Children, Toronto, ON, Canada; Program in Developmental and Stem Cell Biology, SickKids Research Institute, Toronto, ON, Canada; Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Department of Paediatrics, University of Toronto, Toronto, ON, Canada. Electronic address: ashish.deshwar@sickkids.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoribosylpyrophosphate synthetase (PRS) deficiency is a rare X-linked disorder caused by variants in the PRPS1 gene. While males typically exhibit severe phenotypes, heterozygous females may or may not be affected, most likely explained by skewed X chromosome inactivation and its impact on enzyme activity. In this study, we describe and study both unique and previously described variants in PRPS1 in female patients. We provide detailed molecular and phenotypic information for two pediatric patients who possess unique variants in PRPS1, one of whom presents with bilateral tongue fasciculations, extending the cranial neuropathy spectrum described in these conditions. We summarize and compare published cases of females with PRPS1 deficiency to establish common phenotypic features and demonstrate that all disease-causing variants are missense variants scattered across the protein. In silico modeling was performed for all variants causing PRS deficiency in females to highlight different unique impacts on the protein. Altogether, these findings expand the molecular and phenotypic spectrum of PRS deficiency in females, demonstrate that heterozygous females can manifest significant neurological and sensory impairment early in life, and highlight cranial nerve XII involvement. Continued functional and clinical studies are required to refine genotype-phenotype correlations and inform targeted diagnostic and therapeutic strategies.

Indexed as

Genetic Diseases, X-LinkedRibose-Phosphate PyrophosphokinaseFemaleGenetic Association StudiesHumansMutation, MissensePhenotypePRPS1 protein, humanRibose-Phosphate Pyrophosphokinasephosphoribosylpyrophosphate synthetase 1PRPS1PRS deficiency

Identifiers

PMID41928471
PMCPMC13133926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.